Abingdon Health (LON:ABDX) Issues Quarterly Earnings Results

Abingdon Health (LON:ABDX) issued its quarterly earnings results on Tuesday. The company reported GBX (0.51) EPS for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 34.31% and a negative net margin of 19.36%.

Abingdon Health Stock Down 5.6%

ABDX traded down GBX 0.50 during midday trading on Friday, reaching GBX 8.50. 86,284 shares of the company were exchanged, compared to its average volume of 234,171. The company has a market cap of £21.48 million, a price-to-earnings ratio of -10.49 and a beta of 0.13. The company’s fifty day moving average price is GBX 10.63 and its 200 day moving average price is GBX 10.53. Abingdon Health has a one year low of GBX 5.50 and a one year high of GBX 13. The company has a debt-to-equity ratio of 21.99, a quick ratio of 1.96 and a current ratio of 1.91.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.